Based on the SMILES c1ccc2c(c1)OCC(C1=NCCN1)O2, the molecule has a drug half life time in humans after IV administration of 4.200 hours.
Based on the {SMILES__description} {#representation |!}{SMILES#}, the molecule has a {half_life_duration__names__noun} of {half_life_duration#} {half_life_duration__units}.
2-(2,3-dihydro-1,4-benzodioxin-3-yl)-4,5-dihydro-1H-imidazole